Vimarsana
Biggest News Aggregation in the World

Page 11 - Smab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Smab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Smab Today - Breaking & Trending Today

CNN CNN Newsroom With Fredricka Whitfield June 4, 2024 20:39:00 - Vimarsana News

CNN CNN Newsroom With Fredricka Whitfield June 4, 2024 20:39:00

>> nearly half the cancer deaths in the world could be prevented is incredible. >> drinking alcohol contributed to 44% of cancer deaths in 2014. number nine, a new alzheimer's drug appears to be a first to slow the progression of cog any ty decline. the mab stands for monoclonal antibody. the lab works to remove plaques from the brain. the build-up of the protein can block nurl pathways. researchers found that the drug slowed cognitive decline by 27 paterson. >> that's maybe a first medication we have that is a positive result so far but we have to be cautious. >> while the data is encouraging

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Update: - Vimarsana News

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Update:

NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of...

YMAB Investor Alert: Kaplan Fox Investigates Potential - Vimarsana News

YMAB Investor Alert: Kaplan Fox Investigates Potential

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs...

Breaking News for Y-mAbs Therapeutics, Inc. Investors: - Vimarsana News

Breaking News for Y-mAbs Therapeutics, Inc. Investors:

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law...

Y-mAbs Therapeutics Investigated by Block & Leviton For - Vimarsana News

Y-mAbs Therapeutics Investigated by Block & Leviton For

BOSTON , Oct. 26, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) for potential securities law...